Stocks
Horizon Therapeutics Public Limited CompanyHZNP
NASDAQHealthcareBiotechnology$116.30+0.00%
Focused on medicines for rare diseases and autoimmune conditions, the company develops and markets specialty therapies including treatments for thyroid eye disease and chronic gout. Its portfolio is built around high-priced biologics and niche indications that generate outsized revenue from relative...
Market Cap: $26.6B52W Range: $116.30 – $116.34
Congressional Interest in Horizon Therapeutics Public Limited Company (HZNP)
5 members of Congress have disclosed 11 trades in Horizon Therapeutics Public Limited Company (HZNP), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
11
Unique Politicians
5
Buys
5
Sells
6
Who in Congress Is Trading HZNP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-02-03 | Greg Landsman | sell | $1K – $15K |
| 2023-02-01 | Greg Landsman | sell | $1K – $15K |